- Home
- Peptides
- Neuropeptides
- Vasopressin
What Is Vasopressin? Benefits, Research & Safety
A hormone essential for water balance and blood pressure regulation, also involved in social behavior and stress responses.
Quick Facts
In This Guide
Overview
Discovery & History
Mechanism of Action
[Molecular Structure Diagram Placeholder]
Researched Benefits
Based on preclinical and clinical research findings:
- 1Effective treatment for central diabetes insipidus (as desmopressin)
- 2Management of nocturnal enuresis/bedwetting (desmopressin)
- 3Treatment of von Willebrand disease (desmopressin)
- 4Vasopressor support in septic shock
- 5Cardiac arrest protocols
- 6Research into social behaviour modulation
- 7Potential applications in psychiatric conditions (investigational)
Theoretical Dosing & Protocols
| Theoretical Dosage | Varies greatly by indication and analogue used |
| Frequency | Indication-dependent; from once daily to continuous infusion |
| Duration | Chronic for diabetes insipidus; acute for critical care |
| Notes | Vasopressin and its analogues (especially desmopressin) have established medical uses. Use must be under medical supervision with appropriate monitoring. Water intake restriction may be necessary to prevent water intoxication. |
Administration Routes
Routes studied in research settings (educational only):
- Intravenous (critical care, severe diabetes insipidus)
- Subcutaneous (some protocols)
- Intranasal (desmopressin for diabetes insipidus, bedwetting)
- Oral (desmopressin tablets available)
| Half-Life | Stability |
|---|---|
| 10-20 minutes in plasma (vasopressin); longer for desmopressin | Injectable solutions per manufacturer specifications; desmopressin formulations have defined stability |
Safety Profile & Known Risks
Commonly Reported Side Effects
- Water retention
- Headache
- Nausea
- Abdominal cramps
- Nasal congestion (intranasal route)
- Hypertension (vasopressin)
Rare Risks & Concerns
- Water intoxication and hyponatraemia (serious)
- Seizures from hyponatraemia
- Cardiac ischaemia (vasoconstriction)
- Allergic reactions
Contraindications
- Conditions with fluid/electrolyte imbalances
- Coronary artery disease (relative)
- Hyponatraemia
- Polydipsia or inappropriate thirst mechanisms
UK & EU Regulatory Context
🇬🇧 United Kingdom
Vasopressin and desmopressin licensed for various indications including diabetes insipidus, nocturnal enuresis, and haemostasis.
🇪🇺 European Union
Approved for similar indications across member states.
Clinical Studies Summary
Desmopressin for Diabetes Insipidus
Extensive clinical experience confirming desmopressin as first-line treatment for central diabetes insipidus.
Vasopressin in Septic Shock
Trials including VASST and VANISH investigating vasopressin in vasodilatory shock.
Looking for Vasopressin?
Source research-grade Vasopressin from a trusted UK supplier — third-party tested with certificate of analysis.
View at SupplierFrequently Asked Questions
Related Peptides
Oxytocin
A natural hormone and neurotransmitter involved in social bonding, childbirth, lactation, and emotional regulation with therapeutic applications.
Learn moreACTH
A pituitary hormone that stimulates cortisol production, used diagnostically and therapeutically for various conditions including infantile spasms.
Learn moreVIP
A neuropeptide with vasodilatory, anti-inflammatory, and immunomodulatory properties, researched for various therapeutic applications.
Learn more